Search Results - "Al Freijat, Faraj"
-
1
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial
Published in The lancet oncology (01-09-2022)“…Even after resection of early-stage non-small-cell lung cancer (NSCLC), patients have a high risk of developing recurrence and second primary lung cancer. We…”
Get full text
Journal Article -
2
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study
Published in European journal of cancer (1990) (01-07-2019)“…Patients with stage IV non-small-cell lung cancer (NSCLC) and BRAF V600 mutations may benefit from targeted therapies. Chemotherapy outcomes are little known…”
Get full text
Journal Article -
3
Simple Aspiration versus Drainage for Complete Pneumothorax: A Randomized Noninferiority Trial
Published in American journal of respiratory and critical care medicine (01-06-2023)“…Management of first episodes of primary spontaneous pneumothorax remains the subject of debate. To determine whether first-line simple aspiration is…”
Get full text
Journal Article -
4
Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting
Published in European journal of cancer (1990) (01-10-2024)“…The KBP studies are real-life nationwide, prospective, multicenter cohort studies of patients diagnosed with primary lung cancer that have been conducted in…”
Get full text
Journal Article -
5
Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
Published in The Lancet regional health. Europe (01-11-2022)“…Long-term changes in lung cancer (LC) patients are difficult to evaluate. We report results from the French KBP-2020 real-life cohort. KBP-2020 was a…”
Get full text
Journal Article -
6
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts
Published in ESMO open (01-06-2024)“…The impact of the most recent advances, including targeted therapies and immune checkpoint inhibitors, on early (3-month) mortality in lung cancer is unknown…”
Get full text
Journal Article